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Abstract
Objective. To assess the quality of clinical care provided to patients with HIV in Felege Hiwot Referral Hospital.
Approach and design. Normative evaluation based on Donabedian’s structure–process–outcome model of health care
quality. Cross-sectional study design was employed to gather data in September 2007.
Setting. Felege Hiwot Referral Hospital is a government hospital in North West Ethiopia. The hospital is providing clinical
care for patients infected with HIV free of patient charge since 2005.
Measures. The evaluation used 10 process and 5 outcome indicators of quality measured by reviewing 351 randomly selected
patient records and interview with 368 patients. Resource inventory was conducted to assess the availability of trained staff,
laboratory facilities and drugs required for provision of HIV care.
Results. All resources recommended by the national antiretroviral therapy (ART) Implementation Guideline including trained
staff, laboratory facilities and drugs were continuously available, except for a shortage of cotrimoxazole. Despite this, impor-
tant components of care and treatment recommended by national treatment guidelines were not delivered for signiﬁcant
portion of patients. The study showed that only 45.9% of patients eligible for cotrimoxazole prophylactic therapy (CPT) and
76.8% of patients eligible for ART were actually taking CPT and ART, respectively. Compliance with national guidelines to
monitor patients was also found to be a major problem.
Conclusion. Availability of resources alone does not ensure the quality of HIV care and treatment. The study results indicate
a need for regular monitoring and improvement of processes and outcomes of care in the Ethiopian Health System.
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Introduction
Like in other Sub-Saharan African Countries, HIV/AIDS is
a major public health, social and economic problem in
Ethiopia. As part of the multi-sectoral response to mitigate
the impact of the pandemic and through the support of
PEPFAR and Global Fund, the government is providing
medical care services to People Living with HIV/AIDS free
of charge [1–3].
Time and again, researches have revealed that medical care
prolongs and improves the quality of life of patients infected
with HIV/AIDS. However, the outcomes of clinical care for
patients depend not only on attending a clinical care provider
but also on appropriate execution of recommended com-
ponents of care including prevention and treatment of
opportunistic infections, use of Highly Active Antiretroviral
Therapy (HAART) and laboratory and clinical follow-up of
patients [4–8].
Felege Hiwot Referral Hospital is one of the three referral
hospitals in Amhara National Regional State of Ethiopia.
The hospital uses the national guidelines for the management
of opportunistic infections and ART to manage
HIV-infected patients [4, 5]. By the end of August 2007, a
total of 6396 patients were registered for HIV care out of
which 5031 (78.7%) started ART. Out of those patients who
started ART, 3225 (64.1%) were reported as taking
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ing 1806 (35.9%) failed to follow-up, transferred out to other
health facilities or died [9].
To date, in Ethiopia, there exists neither an established
system of quality management nor a comprehensive study
assessing the quality of HIV clinical care. But some studies
conducted outside Ethiopia showed that quality of medical
care is indeed a major problem that needs to be addressed
systematically [10–14]. A speciﬁc study conducted to assess
adherence of patients with HAART in Addis Ababa also
showed that adherence to antiretroviral drugs is a problem
even though it is better when compared with that of patients
in more urban settings [15].
Objective
To assess the quality of clinical care provided to patients
infected with HIV in Felege Hiwot Referral Hospital.
Indicator selection
Quality of care indicators were set based on national guide-
lines for the treatment of patients with HIV/AIDS in
Ethiopia [4, 5] after a thorough review on the quality of
HIV/AIDS care literature. The selected indicators were again
reviewed by physicians working on HIV/AIDS control
program as well as HIV care-providing facilities for their
local relevance. After all these procedures, a total of 15 indi-
cators were selected. Ten indicators were on the process of
care while the rest ﬁve indicators were on outcomes of care.
Measurement
Donabedian’s structure–process–outcome model of health care
quality was employed as a framework for the study [14, 16].
Data on the structure, processes and outcomes of care were
collected cross-sectionally in September 2007. The measures
included:
(1) Availability of resources required to provide HIV clini-
cal care service
(2) Compliance of HIV clinical care practice with national
guidelines
(3) Outcomes of care including behavioral, immunologic
and clinical conditions
Resource inventory was conducted to assess the availability
of resources, including trained staff, laboratory facilities, anti-
retroviral drugs and opportunistic infection prophylactic
drugs. An inventory tool prepared based on the resource
requirements of the national program for health facilities pro-
viding ART was used for this purpose.
The process and outcome indicators were assessed by
reviewing 351 randomly selected patient records. Of the total
records reviewed, 233 (66.4%) were patients on ART and the
remaining 118 (33.6%) were on chronic care before ART
initiation, which was based on the actual proportion of
patients in the two categories of care. In addition, an exit
interview was conducted with 368 patients visiting the HIV
clinic during the data collection period to assess satisfaction
of patients. Interviews were conducted by trained data collec-
tors using a satisfaction questionnaire adapted from the
HIVQUAL project of New York State Department of
Health AIDS Institute [17], which included 29 satisfaction
measuring variables against a ﬁve-level satisfaction score.
SPSS version 12.0.1 software was used to analyze the data.
Inclusion and exclusion criteria
Patients who have been in care and treatment for at least 6
months were eligible for record review. With the purpose of
assessing recent practices, patients who had no clinic visit
during the 1-year period prior to data collection were
excluded. Patients who transferred in or out to other health
facilities were also excluded from the study to keep focus on
quality practice in the study hospital. For the patient interview,
patients who visited the clinic for the ﬁrst time were excluded
as they may not have adequate prior experience with the hos-
pital to provide meaningful answers to the questions.
Results
Resource availability
HIV clinical care in Felege Hiwot Referral Hospital is pro-
vided in a separate clinic. Daily, the ART unit is staffed with
two general practitioners and seven nurses who took part in
in-service trainings on HIV/AIDS clinical care provision
based on the national guideline. The HIV clinic uses labora-
tory services from two sources: the hospital laboratory
department and the Regional Health Research Laboratory,
which is located in the hospital’s compound. The hospital’s
laboratory provides routine laboratory tests, including HIV
testing, microscopy for TB diagnosis and stool examination.
For other HIV/AIDS-related laboratory tests including CD4
measurement, liver function test, renal function test
and hematology analysis, it uses the Regional Research
Laboratory. All the required laboratory tests, based on the
National ART Implementation Guideline, are available in either
the hospital’s laboratory unit or the regional laboratory.
During the 6-month period prior to data collection, the
hospital’s drug store lacked stock of the ﬁrst line antiretro-
viral drugs, Stavudine and Zidovudine. The cumulative
period without stock of these drugs was for 2 and 8 days,
respectively. But the drug supply was not interrupted in the
dispensing unit. There was no stock of cotrimoxazole in
either the store or the dispensary for 2 months prior to and
during the data collection period.
Background characteristics of study subjects for
chart review
Table 1 presents the background characteristics of study
population. The review included 351 records of patients. The
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357median duration in care and treatment was found to be 15.5
months (IQR: 12.13 months). One hundred twenty-one
(34.5%) were enrolled within 1 year prior to the data collec-
tion period while the remaining 230 (65.5%) have been fol-
lowing care for more than 1 year.
Compliance of HIV clinical care with national
guidelines
Compliance with national guidelines [4, 5] for the provision
of HIV clinical care was assessed based on 10 selected
process indicators on 351 patient records, of which 233
(66.4%) were on ART and the remaining 118 (33.6%) were
patients in care prior to ART initiation. The performance of
the hospital in regard to the selected process indicators is
presented in Table 2 and ﬁndings revealed major problems
in adherence with national guidelines for HIV clinical care
provision.
According to the national guidelines, 267 (76.1%) of the
351 sample patients were eligible for ART. Among these,
only 205 (76.8%) were actually taking ART while 34 (12.7%)
of them never started ART and the rest 28 (10.5%) failed to
continue treatment after initiation. Of the 118 patients who
were in care before ART initiation, 34 (28.8%) were actually
eligible for ART but had not yet started it.
Out of the 351 patients included in this study, 236
(67.2%) had a most recent CD4 count of less than 350
cells/ml that makes them eligible for CPT according to the
national guidelines. The result showed that only 179 (75.8%)
of these eligible patients were prescribed CPT during their
last HIV clinic visit. Furthermore, the clinic was able to
maintain continuity of care only for 146 (81.6%) of those
patients who were prescribed with CPT during their last visit.
Exit interviews with patients attending the HIV clinic
showed that only 74.3% of patients prescribed with CPT
during their previous clinic visit took their prophylactic
drugs. Continuity of care was assessed against this standard
and was found to be maintained for only 249 (70.9%)
patients. It was 88.0% for patients taking ART and 37.3%
for patients in care before ART initiation.
According to the national guideline on management of
patients with HIV infection [4], a patient with HIV is
expected to visit HIV clinic at least once every 6 months
prior to ART initiation and every 3 months after ART
initiation. Continuity of care was assessed against this stan-
dard and was found to be maintained for only 249 (70.9%)
patients. It was 88.0% for patients taking ART and 37.3%
for patients in care before ART initiation.
Behavioral and health outcomes
Achievement of desired behavioral and health outcomes was
measured by the level of patients’ adherence to prescribed
drugs, immunologic status of patients, clinical improvement
(improvement in functional status of bedridden or ambulat-
ory patients) and satisfaction of patients. Table 3 presents
the ﬁndings on speciﬁc outcome indicators of care and
treatment.
Adherence to antiretroviral drugs and to CPT was
measured by interviewing patients on the number of doses
missed during 1-week period prior to the date of interview.
If a patient was taking 95% or more of prescribed pills, this
was deﬁned as good adherence. The result from the inter-
view showed that 338 (97.7%) of patients on ART and 182
(65.2%) of those on CPT had good adherence to their
respective prescribed drugs. Among respondents of the inter-
view who were prescribed with CPT, it was found that 72
(25.8%) of them were not taking the drugs at all.
Out of the 331 patients who had their CD4 count
measured at least once, ﬁrst-time CD4 count was greater
than 200 cells/ml for 150 (45.3%) of the patients. After
varying period in care and/or treatment, most recent CD4
count was greater than 200 cells/ml for 200 (60.4%) of
....................................................................................
Table 1 Background characteristics of study subjects for
chart review, Felege Hiwot Referral Hospital, September
2007
Variable Category Number Percent
Sex Male 159 45.3
Female 192 54.7
Total 351 100.0
Age (completed
years)
,5 9 2.6
5–14 14 4.0
 15 328 93.4
Total 351 100.0
Marital status Married 97 27.6
Never married 34 9.7
Widowed 28 8.0
Divorced 50 14.2
Not documented 142 40.5
Total 351 100.0
Educational
status
No education 92 26.2
Primary education 29 8.3
Secondary education 70 19.9
Tertiary education 18 5.1
Not documented 142 40.5
Total 351 100.0
Occupation Civil servant 26 7.4
Farmer 12 3.4
Housewife 19 5.4
Merchant 19 5.4
Daily labor 39 11.1
Others 24 6.8
Not documented 212 60.4
Total 351 100.0
Address (Zone) Bahir Dar (The city
where the hospital is
located)
200 57.0
Outside of Bahir Dar 151 43.0
Total 351 100.0
On HIV
treatment /
ART
Yes 233 66.4
No 118 33.6
Total 351 100.0
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358them. Among patients who were taking ART, CD4
measurements at baseline, 6, 12 and 18 months after ART
were found documented for 199, 69, 53 and 23 patients,
respectively. The result of this study showed an increase in
median CD4 count with duration on ART. Fig. 1 presents
the trend in median CD4 count with duration on ART. As
shown in the ﬁgure, the median baseline CD4 count
was found to be 275 cells/ml (IQR: 157, 403 cells/ml) at
.............................................................................................................................................................................
Table 2 Summary of performance on process indicators of quality, Felege Hiwot Referral Hospital, September 2007
Processes indicators Number of eligible
patients
Achievement,
P (95% CI)
Care during enrollment to HIV clinic
Proportion of patients who received their ﬁrst-time CD4 count within 2 weeks
after ﬁrst HIV clinic visit
121 90.9% (85.8–96.0)
Opportunistic infection prevention
Proportion of patients whose CD4 count is ,350 cells/ml who currently are
on cotrimoxazole prophylactic therapy
236 45.9% (39.5–52.3)
ARV therapy and follow-up
Proportion of patients with continued care 351 70.9% (66.1–75.7)
Proportion of patients who had CD4 count measured at least once during the
last 6 months
351 20.8% (16.6–25.0)
Proportion of patients eligible for ARV who are currently on ARV 267 76.8% (71.7–81.9)
Proportion of patients on ART who are started on ART within 2 weeks after
clinical eligibility is conﬁrmed
233 86.3% (82.5–91.1)
Proportion of patients on NVP who had LFT at least once within 1 month
after initiation of NVP-based ART
179 0.0%
Proportion of patients on ART for whom adherence is measured on last three
visits
218 28.0% (22.1–33.9)
Record completeness
Proportion of patients with previous ARV regimen change for whom reason
for change in regimen is documented
26 53.8% (35.3–72.3)
Proportion of patients on ARV who had registered own and contact address 351 41.9% (36.7–47.1)
....................................................................................
Table 3 Summary of performance on outcome indicators of
quality, Felege Hiwot Referral Hsopital, September 2007
Outcome indicators n Achievement,
P (95% CI)
Adherence to medications
Proportion of patients on
ARV with at least 95% (good)
reported adherence on last visit
346 97.7% (96.1–99.3)
Proportion of patients on
cotrimoxazole prophylaxis with
at least 95% reported
adherence on last visit
279 65.2% (59.6–70.8)
Immunologic and clinical response to HIV care
Proportion of patients with
CD4 count greater than 200
cells/ml
331 60.4% (55.1–65.7)
Proportion of either
bedridden or ambulatory
patients who have
improvement in functional
status
92 71.7% (62.5–80.9)
Patient satisfaction
Average of patient
satisfaction score
368 78.0% (73.8–82.2)
Figure 1 CD4 count of patients on HAART across time
after ART initiation, Flege Hiwot Referral Hospital,
September 2007.
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35918 months of treatment when compared with that of
baseline CD4 count which was 127 cells/ml (IQR: 74, 191
cells/ml).
Patients’ self-reported functional status was one of the
patient monitoring measures recommended by the national
treatment guideline. Working, ambulatory and bed ridden
were the categories used for this purpose. Among the study
subjects, functional status was assessed and documented
during enrollment to care for 246 (70.1%) of them. Out of
these, 154 (62.6%) were working; 77 (31.3%) were ambulat-
ory and 15 (6.1%) were bedridden. Of the total 92 patients
who were either bedridden or ambulatory, 66 (71.7%)
showed improvement from ambulatory to working, bedrid-
den to ambulatory or bedridden to working.
On the basis of the patient satisfaction survey, the average
level of satisfaction was 3.9 out of 5 points (78.0%). Average
rate of satisfaction was relatively higher for variables related
with provider–patient interaction for which the average satis-
faction score was 4.4 out of 5 points. On the other hand, the
satisfaction score was relatively lower for affordability of care
which was mainly related with the non-medical cost of visit-
ing the HIV clinic. The average satisfaction score for this
dimension was 3.2 out of 5 points. Table 4 presents the
number of satisfaction questions under each satisfaction
dimension and the level of satisfaction of patients on each of
satisfaction dimensions.
Discussion
This evaluation study used an indicator-driven approach for
the measurement of HIV care quality and has addressed
three components of quality—structure, process and
outcome. The results show that a signiﬁcant portion of
patients attending HIV clinic in the study hospital were
missing important components of care recommended by
the national guidelines. Although there were important
improvements in many patients’ immunologic and clinical
conditions, achievement of these desired patient outcomes
needed further improvement. The presence of all the
required resources, except an observed shortage of cotrimox-
azole, to provide HIV care reveals a vast opportunity for the
hospital to improve process and outcome indicators of
quality. A relatively better quality of care was provided to
patients on enrollment in care with 90.9% of the patients
received their ﬁrst CD4 count within 2 weeks after ﬁrst HIV
clinic visit. For the remaining components of care expected
to be provided as follow up care, the hospital failed to
provide recommended care for signiﬁcant portion of its
HIV-infected patients.
A number of studies have shown that CPT prevents the
occurrence of fatal opportunistic infections among patients
with HIV infection [18–21]. World Health Organization and
UNAIDS also recommended the use of CPT for patients
with symptomatic HIV infection [22]. Considering these rec-
ommendations, the national CPT guideline has made a rec-
ommendation to prescribe CPT for HIV-infected patients
with CD4 count of less than 350 cells/ml [5]. In this respect,
the ﬁnding from this evaluation study showed that out of the
sample patients who were eligible for CPT, only about 45.9%
were actually on CPT. This considerably low achievement
was because of failure to prescribe CPT for eligible patients
during clinic visits, lower rate of continuity of care and poor
compliance of patients with CPT.
Timely initiation of appropriate ART is one of the basic
components of chronic HIV care which determines the
outcome of HIV clinical care. Many studies have proved that
antiretroviral therapy reduces morbidity and mortality among
patients with HIV [6, 7, 23, 24]. The Ethiopian standard on
the time to start ART is based on the World Health
Organization’s recommendation for resource-limited settings
[25]. According to the national ART guideline, patients need
to be started on ART if they have clinical stage IV disease,
clinical stage III disease with CD4 count less than 350 cells/
ml or those with CD4 count less than 200 cells/ml irrespec-
tive of their clinical stage [4].
According to this study, the study hospital was able to
keep 76.8% of eligible patients on ART. Nearly 13% of the
eligible patients were never started on ART and the remain-
ing 10.5% failed to follow-up after starting ART. This
showed that there are HIV patients who are eligible but have
not yet been put on ART. In concrete terms, more than a
quarter (28.8%) of HIV-infected patients who were in care
before ART initiation did not start ART although they
should have been started according to the recommendation
in the national treatment guideline. This ﬁnding appears to
be an issue for discussion among HIV/AIDS program man-
agers who are determined to expand the service to health
centre level, with the aim of universal access to ART, prob-
ably without due attention to the quality of care in the exist-
ing delivery sites.
Continuity of care was maintained for 88.0% for patients
in care after ART initiation and 37.3% before ART initiation.
....................................................................................
Table 4 Summary of satisfaction levels by dimensions of
satisfaction, Flege Hiwot Referral Hospital, September 2007
Dimensions of
patient
satisfaction
Average
number of
respondents
Number of
questions
Mean
satisfaction
score
Availability of
resources
345 7 3.4
Perceived quality
of care
317 7 4.0
Health worker–
patient interaction
320 8 4.4
Accommodation
and time
management
312 5 4.0
Affordability of
care
365 2 3.2
Average of all
indices
327 29 3.9
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a strong system of patient-tracing mechanism. Unfortunately,
documentation of patients’ own and contact address was
poor; only 41.9% of patients had a complete address docu-
mented in their records, making tracing of patients difﬁcult.
Time and again, studies have shown that outcome of
HAART is strongly associated with adherence to antiretro-
viral drugs [26–30]. This study showed that good adherence
to antiretroviral drugs was achieved in 97.7% of the patients.
This result was higher compared with a similar measure in a
more urbanized setting of Addis Ababa where the pro-
portion of patients with good adherence was 81.2% which
was considered even better when compared with the situ-
ation in the developed world [15]. However, adherence to
CPT was low; only 65.2% of patients prescribed with CPT
had good adherence to CPT during the week prior to the
data collection day and 25.8% were not taking the drug at all
even though it was prescribed by their providers.
The overall process of care for patients with HIV is to
keep patients protected from opportunistic infections, by
improving their immunological status [4]. A patient’s CD4
count less than 200 cells/ml is a strong marker for the poss-
ible occurrence of opportunistic infections [31]. The last
CD4 count among the sample HIV-infected patients was
found to be greater than 200 cells/ml in 60.4% (n ¼ 351) of
them when compared with that of ﬁrst-time CD4 count
which showed that only 45.3% of the patients had CD4
count of greater than 200 cells/ml. CD4 measures at base-
line, 6, 12 and 18 months after ART initiation also showed
improvement in immunologic status of patients with time on
ART. Despite this improvement, there is a huge gap for
improvement to keep all patients with CD4 count of at least
200 cells/ml. This ﬁnding should alert relevant stakeholders
to give emphasis on prophylactic therapies and work towards
early enrollment of patients to care and treatment.
Quality of care provided to patients was found to vary
across different components of care. The best care provided
was during ﬁrst time enrollment of patients during which
90.9% of patients received their ﬁrst-time CD4 measurement
within 2 weeks of enrollment. For most of the rest care com-
ponents expected to be provided during follow-up, the
system was able to provide recommended care only for less
than half of the patients. This ﬁnding is comparable to a
study in the USA, which showed that patients are more likely
to receive the recommended HIV care better during their
ﬁrst visit than in follow-up care [11].
The patient record was the main source of process indi-
cators used in this evaluation study. The accuracy and com-
pleteness of the patient record may result in either
underestimating or overestimating some of the indicators. To
date, there are no studies done in Ethiopia to compare the
reliability of methods to measure health care quality, so the
direction of bias introduced by inherent limitations of chart
abstraction is not well understood in our context. However,
some studies outside the country have shown that using
chart review may underestimate quality indicators by a
margin of 5.4 and 10.6% when compared with measures
through the use of clinical vignettes and standardized
patients, respectively [32]. If this holds true in our setting,
the use of standardized patients would have increased the
values of the measured process indices by up to 10%, but
most of the indicators would still fall below the expected
level of performance.
Conclusions
Felege Hiwot Referral Hospital has adequate resources to
provide HIV/AIDS clinical care. However, important com-
ponents of care recommended by the national guidelines
were found to be missed for signiﬁcant proportions of
patients. Although immunologic and clinical improvements
were observed among patients attending the hospital, there is
still a huge gap to maximize beneﬁts to all eligible patients.
The presence of these gaps despite the availability of ade-
quate human and material resources shows that availability of
resources alone will not ensure the quality of clinical services
to patients with HIV infection signifying the need to con-
tinuously monitor and improve process and outcome
measures of quality.
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